After treatment period of 25 days cycle, the tumor volumes of Nrf2 and PRDX5 shRNA group were significantly decreased than that of the other groups and weights of the corresponding tumor were also the smallest (*P < 0.05, **P < 0.01, Figure 8A–8C). The gene discussed is PRDX5; the disease is neoplasm.